INDIVIDUALIZATION OF CUSTOM COMPOUNDED HORMONE THERAPY IN A PATIENT WITH CHEMOTHERAPY INDUCED PREMATURE OVARIAN INSUFFICIENCY AND IMPAIRED LIVER FUNCTION – CASE REPORT

Although the use of commercially manufactured hormone therapy (HT) to treat menopausal symptoms has declined during the past 12 years, the use of custom compounded HT seems to have increased. A 39-year-old woman with refractory anemia sustained premature ovarian insufficiency following allogeneic st...

Descripción completa

Detalles Bibliográficos
Autores principales: Franić, Damir, Sever, Matjaž, Janež, Andrej, Franić-Ivanišević, Maja, Jensterle, Mojca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629201/
https://www.ncbi.nlm.nih.gov/pubmed/31363339
http://dx.doi.org/10.20471/acc.2019.58.01.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629201/
https://www.ncbi.nlm.nih.gov/pubmed/31363339
http://dx.doi.org/10.20471/acc.2019.58.01.21

Ejemplares similares